
Australia’s Therapeutic Goods Administration (TGA) has recently approved a new COVID booster. The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron.
This is now the fifth iteration of the COVID vaccines, which have been updated regularly to keep up with the rapidly evolving virus, SARS-CoV-2.